|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-05-06 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
| 14-05-06 | Actavis : M&A frenzy in healthcare sector | RE |
Company details: Forest Laboratories, Inc.
Forest Laboratories, Inc.
909 Third Avenue
10022-4731, New York
+212-421-7850
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.92% | +1.43% | +83.05% | +128.86% | 1,088B | |
| +0.47% | +1.98% | +50.26% | +50.75% | 629B | |
| +0.83% | +2.85% | +24.49% | +64.82% | 440B | |
| -0.88% | -0.66% | +47.04% | +36.64% | 359B | |
| -0.37% | -0.58% | +28.59% | +36.31% | 291B | |
| +0.05% | -2.73% | +5.61% | +6.15% | 245B | |
| +0.40% | +2.45% | +46.62% | +59.17% | 225B | |
| -0.42% | +1.34% | -6.94% | -51.94% | 204B | |
| +1.67% | +4.84% | +15.10% | +72.68% | 168B | |
| Average | +0.09% | +1.48% | +32.65% | +44.82% | 405.47B | |
| Weighted average by Cap. | -0.13% | +1.36% | +46.83% | +65.97% |
- Stock Market
- Stocks
- Stock
- Company Forest Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
